Grantham, Mayo, Van Otterloo & Co (GMO)’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
12,491
+2,194
+21% +$309K ﹤0.01% 461
2025
Q4
$1.39M Buy
10,297
+36
+0.4% +$4.82K ﹤0.01% 455
2025
Q3
$1.27M Buy
+10,261
New +$1.13M ﹤0.01% 439
2020
Q2
Sell
-84,060
Closed -$1.53M 747
2020
Q1
$1.53M Buy
+84,060
New +$2M 0.01% 435
2019
Q4
Sell
-2,851,100
Closed -$68.8M 685
2019
Q3
$68.8M Buy
2,851,100
+79,200
+3% +$1.83M 0.48% 44
2019
Q2
$66.5M Sell
2,771,900
-179,200
-6% -$4.31M 0.47% 51
2019
Q1
$69.7M Sell
2,951,100
-248,000
-8% -$5.55M 0.5% 43
2018
Q4
$64.8M Buy
3,199,100
+115,600
+4% +$2.48M 0.52% 47
2018
Q3
$72.5M Sell
3,083,500
-1,436
-0% -$33.4K 0.49% 47
2018
Q2
$67.2M Sell
3,084,936
-239,656
-7% -$5.22M 0.48% 50
2018
Q1
$71.6M Buy
3,324,592
+308,800
+10% +$6.95M 0.44% 55
2017
Q4
$66.2M Sell
3,015,792
-18,400
-0.6% -$405K 0.39% 56
2017
Q3
$64.2M Sell
3,034,192
-157,892
-5% -$3.1M 0.38% 61
2017
Q2
$58.9M Buy
3,192,084
+78,000
+3% +$1.42M 0.33% 67
2017
Q1
$55.4M Sell
3,114,084
-32,464
-1% -$562K 0.31% 76
2016
Q4
$52.9M Buy
3,146,548
+239,080
+8% +$3.98M 0.28% 93
2016
Q3
$47.2M Buy
2,907,468
+109,860
+4% +$1.67M 0.22% 111
2016
Q2
$40.1M Buy
2,797,608
+427,436
+18% +$6.15M 0.16% 123
2016
Q1
$34.3M Sell
2,370,172
-589,088
-20% -$7.65M 0.13% 149
2015
Q4
$38.6M Sell
2,959,260
-541,540
-15% -$7.24M 0.14% 124
2015
Q3
$44.6M Sell
3,500,800
-761,480
-18% -$10.2M 0.15% 111
2015
Q2
$61.8M Sell
4,262,280
-639,200
-13% -$9.18M 0.2% 90
2015
Q1
$72.2M Sell
4,901,480
-186,356
-4% -$2.61M 0.22% 79
2014
Q4
$68.4M Buy
5,087,836
+73,596
+1% +$942K 0.18% 85
2014
Q3
$62.6M Buy
5,014,240
+744,288
+17% +$9.33M 0.17% 93
2014
Q2
$51.4M Buy
4,269,952
+3,366,408
+373% +$40.1M 0.14% 91
2014
Q1
$10.4M Buy
+903,544
New +$10.1M 0.03% 204

Other funds holding APH

Grantham, Mayo, Van Otterloo & Co (GMO)'s APH Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Amphenol (APH) stake by 21% in Q1 2026, buying an estimated $309K and bringing the position to 12,491 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in APH in Q1 2014 and has held it in 27 quarters since. The position peaked at $72.5M in Q3 2018. 2,114 funds tracked by Wall St. Rank hold APH as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 12,491 shares of Amphenol worth $1.58M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,194 Amphenol shares in Q1 2026, an estimated $309K.
  • Amphenol made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #461 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amphenol in Q1 2014 and has held it in 27 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Amphenol position peaked at $72.5M in Q3 2018.
  • 2,114 funds tracked by Wall St. Rank held Amphenol as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.